Tokyo, Oct. 7 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059301) titled 'Ancillary Study in Outcomes Research for Ulcerative Colitis using Patient Focused Registry' on Oct. 7.
Study Type:
Observational
Primary Sponsor:
Institute - Takeda Pharmaceutical Company, Limited
Condition:
Condition - Ulcerative colitis
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The objective of this study is to clarify the below 4 points leading to the Outcome improvement (patient report type of outcome such as QOL, recurrence and deterioration, hospitalization and remove of the whole large bowel) by using patient-centric registry established in the precedi...